BioSpace News Archive

REALM IDx, Inc., a leader in integrated diagnostics, announced the company will participate in the upcoming 40th Annual J.P. Morgan Health Care Conference.

Cellusion Inc. announced it has completed a 1.1 billion yen fundraising round led by existing investors DBJ Capital, Keio Innovation Initiative, and SMBC Venture Capital and new investors Gemseki, Toho Holding, Toyo Seikan Group Holdings and University of Tokyo Edge Capital Partners.

Amylyx Pharmaceuticals, Inc. announced the pricing of its upsized initial public offering of 10,000,000 shares of common stock pursuant to registration statements on Form S-1 filed with the U.S. Securities and Exchange Commission at an initial public offering price of $19.00 per share.

Calyxt, Inc., a plant-based synthetic biotechnology company, announced that its pilot BioFactory™ production system, installed in late December 2021, is now operational at its headquarters site in Minnesota.

Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced preliminary unaudited revenue results for the fourth quarter and fiscal year ended January 2, 2022.

Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, announced that it will be participating in H.C. Wainwright’s Bioconnect Conference taking place next week on January 10-13, 2022.

CinCor Pharma, Inc. announced the pricing of its initial public offering of 12,100,000 shares of common stock at a price to the public of $16.00 per share.